Merck Income from Continuous Operations 2010-2024 | MRK

Merck income from continuous operations for the twelve months ending September 30, 2024 was $12.163B, a 163.27% increase year-over-year.

  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.
  • Merck annual income from continuous operations for 2021 was $12.358B, a 173.23% increase from 2020.

Merck Income from Continuous Operations 2010-2024 | MRK

  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.
  • Merck annual income from continuous operations for 2021 was $12.358B, a 173.23% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B